This year’s Symposium took place on September 27 at Berlin Hall.
 |
Today, digitalisation is transforming diabetes care, probably more rapidly than any other therapeutic area. Ever-increasing amounts of health data are becoming available including data from electronic medical records, clinical trials, medical devices, apps, etc. The use of data is reshaping diabetes prevention and care. It is transforming the relationship between people living with diabetes (PwD) and healthcare professionals (HCPs). It has the potential to improve health outcomes, accelerate research and inform policy making. However, the use and sharing of data bring challenges and ethical questions, regarding, for example, data access, privacy and ownership.
During the IDF Europe Symposium at EASDA, on 27 September 2021, a panel comprised of PwD, HCPs and representatives from academia, industry and health authorities discussed the rationale and prerequisites for data sharing and use. They explored how at times divergent interests can also converge to promote PwD engagement and drive holistic changes that benefit PwD and other stakeholders.
Panellists:
• Jose Manuel Boavida, IDF Europe Board Member, President of the Portuguese Diabetes Association (APDP)
• Magda Chlebus, Executive Director for Science and Regulatory Affairs, EFPIA
• Bastian Hauck, IDF Europe Board Members, CEO #dedoc, T1 diabetes advocate
• Kari Kivinen, T2 diabetes advocate
• Niek Klazinga, Head OECD health Quality Indicator Programme
• Stan Shepherd, CEO, Instant Medical Access
• Tanel Ross, Advisor, Supreme Council of Health, Kingdom of Bahrain
• Hugo Van Haastert, Unit B.3, DG Sante
Click here to learn more about our panellists!
Watch the recording of the Symposium here:
